1. Home
  2. IZEA vs CELU Comparison

IZEA vs CELU Comparison

Compare IZEA & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IZEA Worldwide Inc.

IZEA

IZEA Worldwide Inc.

N/A

Current Price

$3.69

Market Cap

78.8M

ML Signal

N/A

Logo Celularity Inc.

CELU

Celularity Inc.

N/A

Current Price

$1.31

Market Cap

40.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IZEA
CELU
Founded
2006
2016
Country
United States
United States
Employees
N/A
123
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
78.8M
40.1M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
IZEA
CELU
Price
$3.69
$1.31
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
56.0K
75.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.07
N/A
Revenue
$20,099,695.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$15.91
$76.00
P/E Ratio
$51.43
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.68
$1.01
52 Week High
$5.86
$4.35

Technical Indicators

Market Signals
Indicator
IZEA
CELU
Relative Strength Index (RSI) 50.84 51.79
Support Level $3.48 $1.21
Resistance Level $3.85 $1.33
Average True Range (ATR) 0.17 0.11
MACD 0.04 0.01
Stochastic Oscillator 57.58 61.10

Price Performance

Historical Comparison
IZEA
CELU

About IZEA IZEA Worldwide Inc.

IZEA Worldwide Inc offers solutions that range from creator agency services to creator technologies to a marketplace that connects marketers with creators. The Company provides value through managing custom content workflow, creator search and targeting, bidding, analytics, and payment processing. The company also enables creators to monetize their content, creativity, and influence through brands and marketers. The company compensates these creators for producing content, such as long and short-form text, videos, photos, status updates, and illustrations, for marketers or distributing such content on behalf of marketers through their websites, blogs, and social media channels.

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: